128
G. Capozzi et al. / Carbohydrate Research 338 (2003) 123–132
CH3ꢀCꢁC), 2.09 (s, 3 H, CH3ꢀCꢁO), 3.18–3.31 (m, 1
H, H-2), 3.30 (B part of an AB system, 1 H, JAB 10.0
Hz, H-6), 3.38 (d, 1 H, J3,4 10.6 Hz, H-4), 3.53–3.62
(m, 2 H, H-1ax, and H-1eq), 3.78 (A part of an AB
system, 1 H, JAB 10.0 Hz, H-6%), 4.04 (as, 2 H,
CH2ꢀBn), 4.14, and 4.27 (AB system, 2 H, JAB 12.2 Hz,
CH2ꢀBn), 5.28 (dd, 1 H, J2,3 10.4 Hz, J3,4 10.6 Hz,
H-3), 7.24–7.35 (m, 10 H, 10 CHꢀAr); 13C NMR (50
MHz, CDCl3) d: 20.9 (CH3ꢀAc), 21.5 (CH3ꢀCO), 30.3
(CH3ꢀCꢁC), 38.8 (C-1), 62.1, 69.6, 71.6, 73.0, 74.2, and
75.3 (C-2, C-3, C-4, C-6, and 2 CH2ꢀBn), 100.6, 102.0,
127.6, 127.8, 127.87, 127.9, 128.4, and 128.4 (10
CHꢀAr), 137.2, and 137.6 (2 Cq), 158.2 (SCꢁC), 169.7
(COꢀAc), 195.9 (CꢁO); Anal. Calcd for C27H30O7S: C,
65.04; H, 6.06. Found: C, 65.29; H, 6.00.
ture was heated to 60 °C for 10 days, then cooled to
room temperature, diluted with CH2Cl2 (3 mL), washed
with a saturated NH4Cl solution (2×) and water (1×)
and dried over Na2SO4. After concentration, the crude
product (62 mg) was purified by flash column chro-
matography on silica gel (CHCl3) to give 17 (15.7 mg,
1
60%) as colourless oil; [a]D −8.89° (c 0.10, CHCl3); H
NMR (200 MHz, CDCl3) d: 2.30 (s, 3 H, CH3), 2.50 (s,
3 H, CH3ꢀCO), 3.41–3.71 (m, 5H, H-1ax, H-1eq, H-2,
CH2-6), 3.86–3.94 (m, 1 H, H-3), 3.89 (d, 1 H, J3,4 10.2
Hz, H-4), 4.59 (AB system, 2 H, JAB 11.2 Hz, CH2ꢀBn),
4.68 (AB system, 2 H, JAB 11.2 Hz, CH2ꢀBn), 4.86 (AB
system, 2 H, JAB 10.6 Hz, CH2ꢀBn), 7.28–7.42 (m, 15
H, 15CHꢀAr); 13C NMR (50 MHz, CDCl3) d: 21.6
(CH3ꢀCO), 30.1 (CH3ꢀCꢁC), 40.6 (C-1), 62.2, 71.5,
73.4, 74.1, 76.6, and 78.2 (C-2, C-3, C-4, and 3
CH2ꢀBn), 100.8 (C-5), 102.1 (SCꢁC), 127.1, 127.4,
127.7, 127.8, 127.9, 128.0, 128.1, 128.2, 128.4, 128.4,
and 128.5 (15 CHꢀAr), 137.3, 137.8, and 138.0 (3 Cq),
158.7 (SCꢁC); 195.6 (CꢁO); Anal. Calcd for C32H34O6S:
C, 70.31; H, 6.27. Found: C, 70.42; H, 6.01.
3.5. 1-{Methyl (4S,5R)-2,6-di-O-benzyl-4-deoxy-a-L-
threo-hexopyranosid[4,5-b]-2-methyl-1,4-oxathiin-3-yl}-
ethanone (16)
To a solution of 2 (200 mg, 0.56 mmol) in 3 mL of
CHCl3, 248.9 mg (0.9 mmol) of phthalimide derivative
11 and 35.4 ml (0.45 mmol) of pyridine were added. The
reaction mixture was heated at 60 °C for 7 days, after
this time the heating was stopped and the mixture
diluted with CH2Cl2 (3 mL), washed with saturated
NH4Cl solution (2×) and water (1×) and dried over
Na2SO4. The organic layer was concentrated and the
crude product (630 mg) was purified by flash column
chromatography on silica gel (4:1 hexane–EtOAc) to
give 16 (140 mg, 51%) and unreacted glycal 2 (30 mg,
60%) as a yellow oil; [a]D −16.99° (c 1.12, CHCl3);
nmax (thin film) 3031 (m), 2923 (s), 1673 (s, CꢁO), 1563
3.7. 1-{Methyl (4S,5R)-2,3,6-tri-O-benzyl-4-deoxy-a-L-
threo-hexopyranosid[4,5-b]-2-methyl-1,4-oxathiin-3-yl}-
ethanone (18)
To a solution of 6 (200 mg, 0.45 mmol) in 3 mL of
CHCl3, 174.5 mg (0.63 mmol) of phthalimide derivative
11 and 28.4 ml (0.36 mmol) of pyridine were added. The
reaction mixture was heated to 60 °C. After 93 h the
heating was stopped and the mixture was diluted with
CH2Cl2 (15 mL), washed with saturated NH4Cl solu-
tion (2×) and water (1×) and dried over Na2SO4. The
organic layer was concentrated to give 288 mg of crude
product which was purified by flash column chromatog-
raphy on silica gel (CH2Cl2) affording the cycloadduct
18 (224 mg, 86%) as yellow oil; [a]D −144.81° (c 0.14,
CHCl3); nmax (thin film) 3031 (m), 2913 (s), 1673 (s,
1
(s, CꢁC) cm−1; H NMR (200 MHz, C6D6) d: 2.14 (s,
3 H, CH3), 2.27 (s, 3 H, CH3CꢁO), 3.34 (s, 3 H, CH3O),
3.39–3.67 (m, 4 H, H-2, H-3, and CH2-6), 3.90 (d, 1 H,
J3,4 10.2 Hz, H-4), 4.46 (AB system, 2 H, JAB 12.0 Hz,
CH2ꢀBn), 4.73 (B part of an AB system, 1 H, JAB 11.4
Hz, CHBꢀBn), 4.82 (d, 1 H, J1,2 8.0 Hz, H-1), 4.96 (A
part of an AB system, 1 H, JAB 11.8 Hz CHAꢀBn),
7.11–7.42 (m, 10 H, 10CHꢀAr); 13C NMR (50 MHz,
CDCl3) d: 21.7 (CH3CꢁO), 30.1 (CH3ꢀCꢁ), 40.0 (C-6),
57.3 (CH3O), 68.3, 71.2, 74.0, 74.7, and 81.4 (C-2, C-3,
C-4, and 2 CH2ꢀBn), 99.8, and 100.6 (C-1, and C-5),
101.8 (SCꢁC); 127.9, 128.0, 128.1, 128.4, and 128.6 (10
CHꢀBn), 137.4, and 138.1 (2 Cq), 158.3 (SCꢁC); 195.6
(CꢁO); Anal. Calcd for C26H30O7S: C, 64.18; H, 6.21.
Found: C, 63.69; H, 6.14.
1
CꢁO), 1563 (s, CꢁC) cm−1; H NMR (500 MHz, C6D6)
d: 1.99 (s, 3 H, CH3), 2.20 (s, 3 H, CH3CꢁO), 3.24 (s, 3
H, CH3ꢀO), 3.43 (B part of an AB system, 1 H, JAB
10.5 Hz, CHBꢀBn), 3.45–3.54 (m, 2 H, H-2, and H-3),
3.60 (A part of an AB system, 1 H, JAB 10.5 Hz,
CHAꢀBn), 3.82 (d, 1 H, J3,4 10.0 Hz, H-4), 4.33 (AB
system, 2 H, JAB 12.0 Hz, CH2ꢀBn), 4.54 (B part of an
AB system, 1 H, JAB 11.2 Hz, CHBꢀBn), 4.68–4.83 (m,
3 H, CH2ꢀBn, and H-1), 4.74 (d, 1 H, J1,2 8.0 Hz, H-1),
4.82 (A part of an AB system, 1 H, JAB 11.5 Hz,
CHAꢀBn), 6.96–7.28 (m, 15 H, CHꢀBn); 13C NMR (50
MHz, C6D6) d: 21.2 (CH3ꢀCꢁO), 29.6 (CH3), 41.0
(C-6), 56.6 (CH3O), 71.59, 73.79, 74.81, 76.29, 76.52,
and 82.79 (C-2, C-3, C-4, and 3 CH2ꢀBn), 100.05, and
101.21 (C-1, and C-5), 102.34, 127.30, 127.55, 127.77,
128.39; 138.02, 138.75, and 138.86 (3 Cq), 157.49, and
194.08 (CꢁO); Anal. Calcd for C33H36O7S: C, 68.73; H,
6.29. Found: C, 68.69; H, 6.61.
3.6. 1{(4S,5S)-1,5-Anhydro-2,3,6-tri-O-benzyl-4-deoxy-
L-threo-hexitol[3,2-b]-2-methyl-1,4-oxathiin-3-yl}-
ethanone (17)
A solution of 5 (20 mg, 0.05 mmol) in 1.5 mL of CHCl3
was treated with 24 mg (0.09 mmol) of phthalimide
derivative 11 and pyridine (3.03 ml). The reaction mix-